2024/53/B/NZ7/01035
Keywords:
NLRP3 inflammasome multiple sclerosis inflammation miRNA anti-CD20 monoclonal antibodies
Descriptors:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Principal investigator (from the host institution):
Number of co-investigators in the project: 7
Call: OPUS 27 - announced on 2024-03-21
Amount awarded: 1 163 138 PLN
Project start date (Y-m-d): 2025-10-01
Project end date (Y-m-d): 2029-09-30
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.